ACRX (update) 11/18 Dsuvia PDUFA AdCom TBA ACRX will resubmit Zalviso IF Dsuvia is approved With recent financing, cash runway extends into H2/19 Dsuvia may benefit from opioid shortages: https://www.cnn.com/2018/03/19/health/hospital-opioid-shortage-partner/index.html?no-st=1533724065